Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Regulatory tracker: Viatris' Ryzumvi lands FDA presbyopia nod
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Donavyn Coffey
Oct 20, 2026 3:00pm
Samsung Bio blunts impact of strike threat with court ruling
Oct 20, 2026 1:40pm
Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue
Brought to you by
Bain & Company
Antheia, DOD shake on $80M manufacturing loan
Oct 20, 2026 11:35am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Cosette lands FDA approval for Evoxac liquid in Sjögren’s
Oct 20, 2026 11:22am